bloated semaglutide Does Make You Bloated? Causes and Management Starting Semaglutide? You might feel
Description
Thats why the FDA gives it a boxed warning
The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity
Below are all of our articles for you to learn about GLP-1s!
Agonista dual GIP+GLP-1 con hasta 22.5% de reduccin de peso
#HealthTips #Gastroenterology #WeightLossJourney
Esta realidade clnica no trivial: a obesidade est associada a um maior risco de diabetes tipo 2,
